Gloucestershire Hospitals NHS Foundation Trust

Specialist MDT: Gloucestershire Hospitals NHS Foundation Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services (updated 2022):

  • Diagnostic Facilities:
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Chemotherapy
  • Support Service Facilities:
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling
    • Genetic counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 426 556
Performance Status recorded 71% 71%
PSA completed 0% 15%
Gleason Score completed 74% 75%
TNM completed 76% 74%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 525 31258
Percentage of men diagnosed with metastatic disease 19% 19%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 20 3680
Percentage of men with low-risk localised disease receiving radical treatment 5% 9%
No. of men diagnosed with locally advanced disease 211 11503
Percentage of men diagnosed with locally advanced disease receiving radical treatment 72% 69%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (Apr 2021 - Mar 2022) 126
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 10%
No. of men who received radical prostatectomy (Sep 2019 - August 2020) 133
Adjusted percentage of men experiencing at least one GU complication (%) 11%
No. of men who received radical radiotherapy (Sep 2019 - August 2020) 226
Adjusted percentage of men experiencing at least one GI complication (%) 16%

Compare provider outcomes